Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LAMOTRIGINE Cause Conjunctival hyperaemia? 120 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 120 reports of Conjunctival hyperaemia have been filed in association with LAMOTRIGINE (Lamotrigine ER). This represents 0.3% of all adverse event reports for LAMOTRIGINE.

120
Reports of Conjunctival hyperaemia with LAMOTRIGINE
0.3%
of all LAMOTRIGINE reports
10
Deaths
107
Hospitalizations

How Dangerous Is Conjunctival hyperaemia From LAMOTRIGINE?

Of the 120 reports, 10 (8.3%) resulted in death, 107 (89.2%) required hospitalization, and 15 (12.5%) were considered life-threatening.

Is Conjunctival hyperaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LAMOTRIGINE. However, 120 reports have been filed with the FAERS database.

What Other Side Effects Does LAMOTRIGINE Cause?

Drug ineffective (5,175) Seizure (3,459) Toxicity to various agents (3,256) Rash (3,249) Foetal exposure during pregnancy (2,985) Off label use (2,625) Completed suicide (2,433) Drug reaction with eosinophilia and systemic symptoms (2,235) Dizziness (2,170) Pyrexia (1,967)

What Other Drugs Cause Conjunctival hyperaemia?

NETARSUDIL (240) LATANOPROST\NETARSUDIL (98) IBUPROFEN (95) ACETAMINOPHEN (67) DUPILUMAB (66) DICLOFENAC (51) BEVACIZUMAB (50) RITUXIMAB (50) DEXAMETHASONE\TOBRAMYCIN (44) BRIMONIDINE (43)

Which LAMOTRIGINE Alternatives Have Lower Conjunctival hyperaemia Risk?

LAMOTRIGINE vs LANADELUMAB LAMOTRIGINE vs LANADELUMAB-FLYO LAMOTRIGINE vs LANREOTIDE LAMOTRIGINE vs LANSOPRAZOLE LAMOTRIGINE vs LANTHANUM

Related Pages

LAMOTRIGINE Full Profile All Conjunctival hyperaemia Reports All Drugs Causing Conjunctival hyperaemia LAMOTRIGINE Demographics